Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Journal article published in 2018 by
Josep Tabernero,
Paulo M. Hoff 
,
Lin Shen,
Atsushi Ohtsu,
Manish A. Shah,
Karen Cheng,
Chunyan Song,
Haiyan Wu,
Jennifer Eng-Wong,
Katherine Kim,
Yoon-Koo Kang
,
Lin Shen,
Atsushi Ohtsu,
Manish A. Shah,
Karen Cheng,
Chunyan Song,
Haiyan Wu,
Jennifer Eng-Wong,
Katherine Kim,
Yoon-Koo Kang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 